Back
Rocket Pharmaceuticals Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
53
RCKT
Rocket Pharmaceuticals
Last Price:
21.31
Seasonality Move:
40.59%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.85 | Buy |
| 20-day SMA: | 19.18 | Buy |
| 50-day SMA: | 20.72 | Buy |
| 200-day SMA: | 24.45 | Sell |
| 8-day EMA: | 19.98 | Buy |
| 20-day EMA: | 19.6 | Buy |
| 50-day EMA: | 20.28 | Buy |
| 200-day EMA: | 22.24 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.57 | Buy |
| Chaikin Money Flow: | -615815 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.27 - 19.97) | Buy |
| Bollinger Bands (100): | (19.48 - 23.36) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 20.84 while RCKT 8-day simple moving average is 19.85, which is a Buy signal.
- The stock price of RCKT is 20.84 while Rocket Pharmaceuticals 20-day SMA is 19.18, which makes it a Buy.
- Rocket Pharmaceuticals 50-day simple moving average is 20.72 while RCKT share price is 20.84, making it a Buy technically.
- RCKT stock price is 20.84 and Rocket Pharmaceuticals 200-day simple moving average is 24.45, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Buy
53
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Buy
The current Rocket Pharmaceuticals [RCKT] share price is $20.84. The Score for RCKT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
1.9B
Price in USD:
20.84
Share Volume:
872.7K
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
16.55
Buy
53
Rocket Pharmaceuticals (RCKT)
is a Buy
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 20.84 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is not overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 20.84 while RCKT 8-day exponential moving average is 19.98, which is a Buy signal.
- The stock price of RCKT is 20.84 while Rocket Pharmaceuticals 20-day EMA is 19.60, which makes it a Buy.
- Rocket Pharmaceuticals 50-day exponential moving average is 20.28 while RCKT share price is 20.84, making it a Buy technically.
- RCKT stock price is 20.84 and Rocket Pharmaceuticals 200-day simple moving average is 22.24, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.25 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Rocket Pharmaceuticals is a Buy
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 56.57, which suggest Rocket Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (18.27 - 19.97), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (19.48 - 23.36), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.